A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- June 2016
- DOI:
- Bibcode:
- 2016PLoSO..1157335G